A novel risk score system based on immune subtypes for identifying optimal mRNA vaccination population in hepatocellular carcinoma.
Hongkai ZhuangChenwei TangHan LinZedan ZhangXinming ChenWentao WangQingbin WangWenliang TanLei YangZhiqin XieBingkun WangBo ChenChangzhen ShangYajin ChenPublished in: Cellular oncology (Dordrecht, Netherlands) (2024)
This novel risk score system based on immune subtypes enabled the identification of RS4 tumor that, due to its highly immunosuppressive microenvironment, may benefit from HCC mRNA vaccination.
Keyphrases